A comparative study of the effects of tissue plasminogen activator and dual antiplatelet therapy on improvement of the score of the National Institutes of Health Stroke Scale in acute ischemic stroke treatment

Vice-chancellery of Research, Birjand University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新: 2018年2月22日

试验速览

暂无简介。

•Proved ischemic stroke; informed consent for participation; stroke symptoms initiated within 4.5 hours before admission; no brain hemorrhage on initial computerized tomography scan; clinical national institutes of health stroke scale between 4 and 18.
•Exclusion criteria: Age 80 years or above; brain hemorrhage in initial computerized tomography scan; history of stroke; history of diabetes mellitus; patients currently receiving oral anticoagulant treatment without considering the international normalized ratio; clinical national institutes of health stroke scale above 25; large ischemic changes of brain or involvement of more than one-third of middle cerebral artery supplying zone in the initial computerized tomography scan.

发起方

Vice-chancellery of Research, Birjand University of Medical Sciences